Lipid-Lowering Pharmacotherapy in Central and Eastern European Countries in Cardiovascular Prevention: Self-Reported Prescription Patterns of Primary Care Physicians

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10191011" target="_blank" >RIV/00216208:11110/13:10191011 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1177/1074248412471196" target="_blank" >http://dx.doi.org/10.1177/1074248412471196</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1177/1074248412471196" target="_blank" >10.1177/1074248412471196</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Lipid-Lowering Pharmacotherapy in Central and Eastern European Countries in Cardiovascular Prevention: Self-Reported Prescription Patterns of Primary Care Physicians

Popis výsledku v původním jazyce

Aims: The aims of this study were (1) to explore physicians' self-reported treatment of patients with dyslipidemia and (2) to identify intercountry differences and associations between physicians' characteristics and treatment patterns. Methods: A cross-sectional survey was performed in primary health care in 9 Central and Eastern European countries. An anonymous questionnaire, which included questions devoted to dyslipidemia treatment, was distributed. Results: A total of 3000 physicians were randomlychosen and 867 responded. The mean percentage of physicians in all countries who reported regular use of statins in primary prevention of cardiovascular diseases (CVD) was 86.4 (range between 91.0% of Polish physicians and 75.7% of Czech physicians; P<.01). In secondary prevention, the mean percentage was only a little higher, 89.9. The use of fibrates for primary prevention was reported by 40.3% of the respondents from Bulgaria and by 2% of the respondents from Estonia (P<.01). Also, si

Název v anglickém jazyce

Lipid-Lowering Pharmacotherapy in Central and Eastern European Countries in Cardiovascular Prevention: Self-Reported Prescription Patterns of Primary Care Physicians

Popis výsledku anglicky

Aims: The aims of this study were (1) to explore physicians' self-reported treatment of patients with dyslipidemia and (2) to identify intercountry differences and associations between physicians' characteristics and treatment patterns. Methods: A cross-sectional survey was performed in primary health care in 9 Central and Eastern European countries. An anonymous questionnaire, which included questions devoted to dyslipidemia treatment, was distributed. Results: A total of 3000 physicians were randomlychosen and 867 responded. The mean percentage of physicians in all countries who reported regular use of statins in primary prevention of cardiovascular diseases (CVD) was 86.4 (range between 91.0% of Polish physicians and 75.7% of Czech physicians; P<.01). In secondary prevention, the mean percentage was only a little higher, 89.9. The use of fibrates for primary prevention was reported by 40.3% of the respondents from Bulgaria and by 2% of the respondents from Estonia (P<.01). Also, si

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of Cardiovascular Pharmacology and Therapeutics

ISSN

1074-2484

e-ISSN

—

Svazek periodika

18

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

234-242

Kód UT WoS článku

000317428000007

EID výsledku v databázi Scopus

—